TRANSTHYRETIN CARDIAC AMYLOIDOSIS REVEALED BY MULTIMODALITY IMAGING IN AN ELDERLY PATIENT WITH HFpEF

Le Quoc Hung 1 , , Tran Trong Phu 2 , Nguyen Van Be Hai 1 , Tran Huong Tra My 1 , Nguyen Van Te 3
1 Bệnh viện Thống Nhất image/svg+xml
2 Trường Đại học Khoa học Tự nhiên, Đại học Quốc gia Thành phố Hồ Chí Minh image/svg+xml
3 Franco-Vietnamese Hospital, Ho Chi Minh City
* Tác giả liên hệ:

Thông tin bài viết

Thống kê
Lượt tải: 10 Lượt xem: 46
Xuất bản
27-02-2026
Chuyên mục
Báo cáo ca lâm sàng

Tải bài viết

Cách trích dẫn

1.
Quoc Hung L, Trong Phu T, Van Be Hai N, Huong Tra My T, Van Te N. TRANSTHYRETIN CARDIAC AMYLOIDOSIS REVEALED BY MULTIMODALITY IMAGING IN AN ELDERLY PATIENT WITH HFpEF. JHA [Internet]. Vietnam; 2026 tháng 2 27 [cited 2026 tháng 2 28];2(7):131–136. https://tcsuckhoelaohoa.vn/bvtn/article/view/184 doi: 10.63947/bvtn.v2i7.17
Loading...
Đang tải trích dẫn...

Tóm tắt

Amyloid cardiomyopathy is an infiltrative disease caused by extracellular deposition of amyloid fibrils within the myocardium, most commonly from immunoglobulin light-chain (AL) or transthyretin (ATTR) sources, leading to progressive heart failure, arrhythmias, and conduction disturbances. We present the case of an 80-year-old man with heart failure with preserved ejection fraction (HFpEF) and comorbidities who was admitted for acute onset dyspnea accompanied by profound hypotension at home. Together with a non-clonal free light-chain profile, these findings supported a diagnosis of transthyretin (ATTR) cardiac amyloidosis. This case highlights the value of integrating electrocardiogram, echocardiography, cardiac magnetic resonance, and bone-avid tracer scintigraphy to establish the diagnosis of ATTR cardiomyopathy and guide management in settings where disease-modifying therapy remains limited.Keywords: supraclavicular brachial plexus nerve block, adductor canal block, popliteal sciatic block, heart failure, limb amputation.

Từ khóa

Amyloid cardiomyopathy transthyretin scintigraphy

Tài liệu tham khảo

  1. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42(16):1554-68. doi: 10.1093/eurheartj/ehab072. PubMed PMID: 33825853; PubMed Central PMCID: PMC8060056.
  2. Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15(7):387-404. Epub 20190617. doi: 10.1038/s41582-019-0210-4. PubMed PMID: 31209302.
  3. Koike H, Katsuno M. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines. 2019;7(1). Epub 20190205. doi: 10.3390/biomedicines7010011. PubMed PMID: 30764529; PubMed Central PMCID: PMC6466231.
  4. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, et al. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). Am J Cardiol. 2021;141:98-105. Epub 20201119. doi: 10.1016/j.amjcard.2020.10.066. PubMed PMID: 33220323.
  5. Ladefoged B, Clemmensen T, Dybro A, Hartig-Andreasen C, Kirkeby L, Gormsen LC, et al. Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS). ESC Heart Fail. 2023;10(1):234-44. Epub 20221003. doi: 10.1002/ehf2.14173. PubMed PMID: 36193570; PubMed Central PMCID: PMC9871677.
  6. Pimenta S, Santos L, Martins A, Santos J, Fortuna I, Pereira B, et al. Screening for Cardiac Amyloidosis When Conducting Carpal Tunnel Surgery. J Clin Med. 2025;14(11). Epub 20250526. doi: 10.3390/jcm14113710. PubMed PMID: 40507472; PubMed Central PMCID: PMC12156134.
  7. Moody WE, Turvey-Haigh L, Knight D, Coats CJ, Cooper RM, Schofield R, et al. British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis. Echo Res Pract. 2023;10(1):13. Epub 20230831. doi: 10.1186/s44156-023-00028-7. PubMed PMID: 37653443; PubMed Central PMCID: PMC10468878.
  8. Nguyen VT. 99mTc-MDP MYOCARDIAL SCINTIGRAPHY IN DIAGNOSIS OF AMYLOID CARDIOMYOPATHY AT FV HOSPITAL, HCM CITY. Tạp chí Điện quang & Y học hạt nhân Việt Nam. 2023(03):46-52. doi: 10.55046/vjrnm.03.1076.2023.
  9. Shah SJ, Fine N, Garcia-Pavia P, Klein AL, Fernandes F, Weissman NJ, et al. Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. JAMA Cardiol. 2024;9(1):25-34. doi: 10.1001/jamacardio.2023.4147. PubMed PMID: 37966817; PubMed Central PMCID: PMC10652219.

Giấy phép

© 2026 Tác giả. Xuất bản bởi Tạp chí Sức khỏe và Lão hóa.